TNFRSF1A and type 2 diabetes mellitus: Previous longitudinal cohorts also demonstrated that higher baseline serum TNFR1 and TNFR2 levels increased the risk of end-stage kidney disease among type 2 diabetes patients (Niewczas et al., 2012; Pavkov et al., 2015).